Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Roche, Global Fund to Build Local Diagnostic Processes

Transporting HIV tests

The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes

AI-Aided Collaboration to Discover Neuro Disease Drugs

Mature neuron

Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients. . . . → Read More: AI-Aided Collaboration to Discover Neuro Disease Drugs

Virtual Reality Studied for Chronic Cancer Pain

Woman with VR headset

A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients. . . . → Read More: Virtual Reality Studied for Chronic Cancer Pain

Intl. Team Studying Antibiotic Overuse in Pigs

Two piglets

Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance. . . . → Read More: Intl. Team Studying Antibiotic Overuse in Pigs

Partnership Developing Faster, Sensitive Covid-19 Test

SARS-CoV-2 and cell

A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test

Ginkgo Acquires Bayer Agricultural Biologics Technology

Iowa cornfield

Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology

Cystic Fibrosis Start-Up Raises $111M in New Funds

Inspecting lung X-rays

A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds. . . . → Read More: Cystic Fibrosis Start-Up Raises $111M in New Funds

Synthetic Bio Companies Partner on Therapeutic Microbes

DNA chip graphic

A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria. . . . → Read More: Synthetic Bio Companies Partner on Therapeutic Microbes

Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

T-cells and cancer cells

A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

NASA Supporting Electric Alternative to Rocket Launch

SpinLaunch accelerator

A company creating an electric-powered launch technology says NASA agreed to a test later this year of a space satellite launched in low earth orbit. . . . → Read More: NASA Supporting Electric Alternative to Rocket Launch